Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Comparison of different clinical outcomes between Group A and Group B

From: Effects of short-term preoperative intranasal dexmedetomidine plus conventional treatment on delirium following cardiac surgery in patients with sleep disorders

Overall outcomes

Group A (n=50)

Group B (n=50)

P Value

Primary outcome

 POD, n (%)

15 (30.0)

6 (12.0)

0.027

Secondary outcome

 Postintervention anxiety, n (%)

12(24)

4(8)

0.029

 Postintervention clinical insomnia, n (%)

13(26)

5(10)

0.037

 Mechanical ventilation duration>12 h, n (%)

41 (82.0)

40 (80.0)

0.799

 Myocardial infarction, n (%)

2(4.0)

0 (0)

0.495

 Stroke, n (%)

0 (0)

0 (0)

-

 CSICU stay (median, IQR, h)

42.5 (21.8,63.3)

25.5 (19.0,67.5)

0.090

 Hospital days (median, IQR, d)

23.5 (19.0,29.3)

24.0 (20.0,28.0)

0.997

 In-hospital mortality, n (%)

0 (0)

0 (0)

-

  1. Data are presented as the median (interquartile range) or n (%).POD postoperative delirium, CSICU Cardiac surgery intensive care unit, IQR interquartile range
Back to article page

Perioperative Medicine

ISSN: 2047-0525